Fresenius Medical Care says U.S. settlement will not affect 2019, 2020 results

FRANKFURT (Reuters) – Fresenius Medical Care AG said that a $231.7 million U.S. settlement reached on Friday to resolve bribery allegations would have no impact on its 2019 and 2020 results because it had already made a financial provision last year.

“Given these accruals already made, the resolutions will have no effect on the company’s 2019 and 2020 outlook,” the Germany-based dialysis clinic operator said after the U.S. Justice Department announced the settlement.

Reporting by Douglas Busvine, editing by Louise Heavens


READ  Nine out of ten health supplements have 'give you no real benefits' claims ex-government advisor 


Please enter your comment!
Please enter your name here